On Thursday, February 6, 2020, the President signed into law:

S. 3201, the “Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act,” which extends for 15 months, through May 6, 2021, the temporary scheduling order classifying certain fentanyl-related substances as a Schedule I drug subject to the strictest controls.